+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biomaterials Market Size, Share & Trends Analysis Report by Product (Natural, Metallic, Polymer), by Application (Cardiovascular, Orthopedics, Plastic Surgery), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4751754
  • Report
  • February 2020
  • Region: Global
  • 190 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BASF SE
  • Collagen Matrix, Inc.
  • CoorsTek Inc.
  • Covalon Technologies Ltd.
  • Evonik Industries AG
  • Johnson & Johnson
  • MORE
The global biomaterials market size is expected to reach USD 348.4 billion by 2027, registering a CAGR of 15.9% over the forecast period. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocyte’s extracellular matrix, thus replacing the traditional organ transplantation procedures.

Further key findings from the report suggest:
  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • North America is expected to dominate the biomaterials market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in November 2019, Evonik partnered with BellaSeno GmbH for development and commercialization of 3D printed breast implant by using Evonik’s RESOMER bioresorbable polymer.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BASF SE
  • Collagen Matrix, Inc.
  • CoorsTek Inc.
  • Covalon Technologies Ltd.
  • Evonik Industries AG
  • Johnson & Johnson
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation

Chapter 2 Executive Summary
2.1 Biomaterials Market Outlook
2.2 Biomaterials Market: Segment Outlook
2.3 Biomaterials Market: Competitive Insights

Chapter 3 Biomaterials Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping For Product, 2019
3.2 Biomaterials Market: Regulatory Framework
3.3 Biomaterials Market: Technology Overview
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising demand as a consequence of accidental injuries & chronic conditions
3.4.1.2 Advances in biomaterials technologies
3.4.1.3 Expansion in the usage scope of biomaterials
3.4.2 Market restraint analysis
3.4.2.1 High expense associated with the development of biomaterials
3.4.2.2 Problems related to biocompatibility of biomaterials
3.5 Biomaterials Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Industry Analysis - Porter’s
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Product developments
3.7.2 Merger & acquisition
3.7.3 Collaboration & partnership
3.7.4 Agreement

Chapter 4 Biomaterials Market Categorization: Product Estimates & Trend Analysis
4.1 Biomaterials Market: Product Movement Analysis
4.2 Metallic
4.2.1 Metallic biomaterials market, 2016 - 2027 (USD Million)
4.3 Natural
4.3.1 Natural biomaterials market, 2016 - 2027 (USD Million)
4.4 Ceramics
4.4.1 Ceramics biomaterials market, 2016 - 2027 (USD Million)
4.5 Polymers
4.5.1 Polymers biomaterials market, 2016 - 2027 (USD Million)

Chapter 5 Biomaterials Market Categorization: Applications & Trend Analysis
5.1 Biomaterials Market: Application Movement Analysis
5.2 Cardiovascular
5.2.1 Cardiovascular market, 2016 - 2027 (USD Million)
5.2.2 Sensors
5.2.2.1 Sensors market, 2016 - 2027 (USD Million)
5.2.3 Stents
5.2.3.1 Stents market, 2016 - 2027 (USD Million)
5.2.4 Guidewires
5.2.4.1 Guidewires market, 2016 - 2027 (USD Million)
5.2.5 ImplanTable cardiac defibrillators
5.2.5.1 ImplanTable cardiac defibrillators market, 2016 - 2027 (USD Million)
5.2.6 Pacemakers
5.2.6.1 Pacemakers market, 2016 - 2027 (USD Million)
5.2.7 Vascular grafts
5.2.7.1 Vascular grafts market, 2016 - 2027 (USD Million)
5.2.8 Others
5.2.8.1 Other cardiovascular applications market, 2016 - 2027 (USD Million)
5.3 Ophthalmology
5.3.1 Ophthalmology market, 2016 - 2027 (USD Million)
5.3.2 Synthetic corneas
5.3.2.1 Synthetic corneas market, 2016 - 2027 (USD Million)
5.3.3 Intraocular lens
5.3.3.1 Intraocular lens market, 2016 - 2027 (USD Million)
5.3.4 Contact lens
5.3.4.1 Contact lens market, 2016 - 2027 (USD Million)
5.3.5 Ocular tissue replacement
5.3.5.1 Ocular tissue replacement market, 2016 - 2027 (USD Million)
5.3.6 Others
5.3.6.1 Other ophthalmology applications market, 2016 - 2027 (USD Million)
5.4 Dental
5.4.1 Dental market, 2016 - 2027 (USD Million)
5.4.2 Tissue regeneration materials
5.4.2.1 Tissue regeneration materials market, 2016 - 2027 (USD Million)
5.4.3 Dental implants
5.4.3.1 Dental implants market, 2016 - 2027 (USD Million)
5.4.4 Bone grafts & substitutes
5.4.4.1 Bone grafts and substitutes market, 2016 - 2027 (USD Million)
5.4.5 Dental membranes
5.4.5.1 Dental membranes market, 2016 - 2027 (USD Million)
5.4.6 Others
5.4.6.1 Other dental applications market, 2016 - 2027 (USD Million)
5.5 Orthopedic
5.5.1 Orthopedic market, 2016 - 2027 (USD Million)
5.5.2 Joint replacement biomaterials
5.5.2.1 Joint replacement biomaterials market, 2016 - 2027 (USD Million)
5.5.3 Orthobiologics
5.5.3.1 Orthobiologics market, 2016 - 2027 (USD Million)
5.5.4 Bio-resorbable tissue fixation products
5.5.4.1 Bio-resorbable tissue fixation products market, 2016 - 2027 (USD Million)
5.5.5 Viscosupplementation
5.5.5.1 Viscosupplementation market, 2016 - 2027 (USD Million)
5.5.6 Spine biomaterials
5.5.6.1 Spine biomaterials market, 2016 - 2027 (USD Million)
5.5.7 Others
5.5.7.1 Other orthopedic applications market, 2016 - 2027 (USD Million)
5.6 Wound Healing
5.6.1 Wound healing market, 2016 - 2027 (USD Million)
5.6.2 Fracture healing device
5.6.2.1 Fracture healing device market, 2016 - 2027 (USD Million)
5.6.3 Adhesion barrier
5.6.3.1 Adhesion barrier market, 2016 - 2027 (USD Million)
5.6.4 Skin substitutes
5.6.4.1 Skin substitutes market, 2016 - 2027 (USD Million)
5.6.5 Internal tissue sealant
5.6.5.1 Internal tissue sealant market, 2016 - 2027 (USD Million)
5.6.6 Surgical hemostats
5.6.6.1 Surgical hemostats market, 2016 - 2027 (USD Million)
5.6.7 Others
5.6.7.1 Other wound healing applications market, 2016 - 2027 (USD Million)
5.7 Tissue Engineering
5.7.1 Tissue engineering market, 2016 - 2027 (USD Million)
5.8 Plastic Surgery
5.8.1 Plastic surgery market, 2016 - 2027 (USD Million)
5.8.2 Facial wrinkle treatment
5.8.2.1 Facial wrinkle treatment market, 2016 - 2027 (USD Million)
5.8.3 Soft tissue fillers
5.8.3.1 Soft tissue fillers market, 2016 - 2027 (USD Million)
5.8.4 Craniofacial surgery
5.8.4.1 Craniofacial surgery market, 2016 - 2027 (USD Million)
5.8.5 Bioengineered skins
5.8.5.1 Bioengineered skins market, 2016 - 2027 (USD Million)
5.8.6 Peripheral nerve repair
5.8.6.1 Peripheral nerve repair market, 2016 - 2027 (USD Million)
5.8.7 Acellular dermal matrices
5.8.7.1 Acellular dermal matrices market, 2016 - 2027 (USD Million)
5.8.8 Others
5.8.8.1 Other plastic surgery applications market, 2016 - 2027 (USD Million)
5.9 Neurology
5.9.1 Neurology market, 2016 - 2027 (USD Million)
5.9.2 Neural stem cell encapsulation
5.9.2.1 Neural stem cell encapsulation market, 2016 - 2027 (USD Million)
5.9.3 Shunting systems
5.9.3.1 Shunting systems market, 2016 - 2027 (USD Million)
5.9.4 Hydrogel scaffold
5.9.4.1 Hydrogel scaffold market, 2016 - 2027 (USD Million)
5.9.5 Cortical neural prosthetics
5.9.5.1 Cortical neural prosthetics market, 2016 - 2027 (USD Million)
5.9.6 Others
5.9.6.1 Other neurology applications market, 2016 - 2027 (USD Million)
5.10 Others
5.10.1 Market for other applications of biomaterials, 2016 - 2027 (USD Million)

Chapter 6 Biomaterials Market Categorization: Regional Estimates & Trend Analysis, by Product & Application
6.1 Biomaterials Market Share by Regions, 2019 & 2027
6.2 North America
6.2.1 North America biomaterials market, 2016 - 2027 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. biomaterials market, by product, 2016 - 2027 (USD Million)
6.2.2.2 U.S. biomaterials market, by application, 2016 - 2027 (USD Million)
6.2.3 Canada
6.2.3.1 Canada biomaterials market, by product 2016 - 2027 (USD Million)
6.2.3.2 Canada biomaterials market, by application, 2016 - 2027 (USD Million)
6.3 Europe
6.3.1 Europe biomaterials market, 2016 - 2027 (USD Million)
6.3.2 Germany
6.3.2.1 Germany biomaterials market, by product, 2016 - 2027 (USD Million)
6.3.2.2 Germany biomaterials market, by application, 2016 - 2027 (USD Million)
6.3.3 U.K.
6.3.3.1 U.K. biomaterials market, by product, 2016 - 2027 (USD Million)
6.3.3.2 U.K. biomaterials market, by application, 2016 - 2027 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific biomaterials market, 2016 - 2027 (USD Million)
6.4.2 Japan
6.4.2.1 Japan biomaterials market, by product, 2016 - 2027 (USD Million)
6.4.2.2 Japan biomaterials market, by application, 2016 - 2027 (USD Million)
6.4.3 China
6.4.3.1 China biomaterials market, by product, 2016 - 2027 (USD Million)
6.4.3.2 China biomaterials market, by application, 2016 - 2027 (USD Million)
6.5 Latin America
6.5.1 Latin America biomaterials market, 2016 - 2027 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil biomaterials market, by product, 2016 - 2027 (USD Million)
6.5.2.2 Brazil biomaterials market, by application, 2016 - 2027 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico biomaterials market, by product, 2016 - 2027 (USD Million)
6.5.3.2 Mexico biomaterials market, by application, 2016 - 2027 (USD Million)
6.6 Middle East Africa
6.6.1 Middle East Africa biomaterials market, 2016 - 2027 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa biomaterials market, by product, 2016 - 2027 (USD Million)
6.6.2.2 South Africa biomaterials market, by application, 2016 - 2027 (USD Million)

Chapter 7 Competitive Landscape
7.1 Company Categorization
7.2 Recent Developments & Impact Analysis, by Key Market Participants
7.3 Public Companies
7.3.1 Company market position analysis
7.4 Private Companies
7.4.1 List of key emerging companies
7.5 Strategy Framework
7.6 Company Profiles
7.6.1 Medtronic
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.2 Evonik Industries AG
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.3 Berkeley Advanced Biomaterials
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.4 CAM Bioceramics B.V.
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.5 Carpenter Technology Corporation
7.6.5.1 Company overview
7.6.5.2 Financial performance
7.6.5.3 Product benchmarking
7.6.5.4 Strategic initiatives
7.6.6 Invibio Ltd.
7.6.6.1 Company overview
7.6.6.2 Financial performance
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.7 BASF SE
7.6.7.1 Company overview
7.6.7.2 Financial performance
7.6.7.3 Product benchmarking
7.6.7.4 Strategic initiatives
7.6.8 Zimmer Biomet Holdings, Inc.
7.6.8.1 Company Overview
7.6.8.2 Financial performance
7.6.8.3 Product benchmarking
7.6.8.4 Strategic initiatives
7.6.9 Covalon Technologies Ltd.
7.6.9.1 Company overview
7.6.9.2 Financial performance
7.6.9.3 Product benchmarking
7.6.9.4 Strategic initiatives
7.6.10 Collagen Matrix, Inc.
7.6.10.1 Company overview
7.6.10.2 Financial performance
7.6.10.3 Product benchmarking
7.6.10.4 Strategic initiatives
7.6.11 Corbion
7.6.11.1 Company overview
7.6.11.2 Financial performance
7.6.11.3 Product benchmarking
7.6.11.4 Strategic initiatives
7.6.12 AdvanSource Biomaterials Corporation
7.6.12.1 Company overview
7.6.12.2 Financial performance
7.6.12.3 Product benchmarking
7.6.12.4 Strategic initiatives
7.6.13 CoorsTek Inc.
7.6.13.1 Company overview
7.6.13.2 Financial performance
7.6.13.3 Product benchmarking
7.6.13.4 Strategic initiatives
7.6.14 PolyNovo Limited
7.6.14.1 Company overview
7.6.14.2 Financial performance
7.6.14.3 Product benchmarking
7.6.14.4 Strategic initiatives
7.6.15 Stryker
7.6.15.1 Company overview
7.6.15.2 Financial performance
7.6.15.3 Product benchmarking
7.6.15.4 Strategic initiatives
7.6.16 Dentsply Sirona
7.6.16.1 Company overview
7.6.16.2 Financial performance
7.6.16.3 Product benchmarking
7.6.16.4 Strategic initiatives
7.6.17 Johnson & Johnson
7.6.17.1 Company overview
7.6.17.2 Financial performance
7.6.17.3 Product benchmarking
7.6.17.4 Strategic initiatives
7.6.18 Noble Biomaterials, Inc.
7.6.18.1 Company overview
7.6.18.2 Financial performance
7.6.18.3 Product benchmarking
7.6.18.4 Strategic initiatives
7.6.19 Kruger Inc.
7.6.19.1 Company overview
7.6.19.2 Financial performance
7.6.19.3 Product benchmarking
7.6.19.4 Strategic initiatives
7.6.20 Cook Biotech Inc.
7.6.20.1 Company overview
7.6.20.2 Financial performance
7.6.20.3 Product benchmarking
7.6.20.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3
  • Medtronic
  • Evonik Industries AG
  • Berkeley Advanced Biomaterials
  • CAM Bioceramics B.V.
  • Carpenter Technology Corporation
  • Invibio Ltd.
  • BASF SE
  • Zimmer Biomet Holdings, Inc.
  • Covalon Technologies Ltd.
  • Collagen Matrix, Inc.
  • Corbion
  • AdvanSource Biomaterials Corporation
  • CoorsTek Inc.
  • PolyNovo Limited
  • Stryker
  • Dentsply Sirona
  • Johnson & Johnson
  • Noble Biomaterials, Inc.
  • Kruger Inc.
  • Cook Biotech Inc.
Note: Product cover images may vary from those shown
Adroll
adroll